Abstract
207P Palbociclib (P) in patients (pts) with solid tumors with CDK4 or CDK6 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have